Advertisement

Topics

Innovus Pharma Announces Agreement with ACON Laboratories, Inc.

06:05 EST 9 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
New FDA-Cleared Urinary Tract Infection Test to be Sold Under the UriVarx™ Brand Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutic...

Other Sources for this Article

Emerging Markets Consulting, LLC
James S. Painter III, 407 340 0226
jamespainter@emergingmarketsllc.com

NEXT ARTICLE

More From BioPortfolio on "Innovus Pharma Announces Agreement with ACON Laboratories, Inc."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...